Fecal microbiota transplantation: past, present and future
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several case reports and animal models have also revealed the probable therapeutic effects of FMT in patients with severe multiple sclerosis, 41 autism, 42 multidrug-resistant organisms (MDRO) infections, 43 and multiple organ dysfunction in critical patients.44”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [42]
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Furthermore, the obese (ob/ob) phenotype has been shown to be transmissible and is adopted in germ- free mice, infused with intestinal microbiota from conventionally raised, genetically obese mice [58].”
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
(1958) · PubMed · Cited by 978
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Research works printed but not linked: 12
- Borody, 1989, ust, 150, 604
- Anathaswamy, 2011, New Scientist, 2796, 8
- Eiseman, 1958, Surgery, 44, 854
- Persky, 2000, Am J Gastroenterol, 95, 3283
- Cohen, 2010, Infect Control and Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
- Huebner, 2006, Gastroenterol Hepatol, 2, 203
- Lund-Tonnesen, 1998, Tidsskr Nor Laegeforen, 118, 1027
- Silverman, 2010, Clin Gastroenterol Hepatol, 8, 471, 10.1016/j.cgh.2010.01.007 · DOI · Paper page
- Andrews, 1995, Gastroenterology, 108, A563
- Borody, 2011, Am J Gastroenterol, 106, S352
- Borody, 2011, Am J Gastroenterol, 106, S352
- Borody, 2011, Am J Gastroenterol, 106, S352
Cited by
Items 201–300 of 335
Clostridium difficileInfection: What's New?
Seo, G. S. (2013) · Intestinal Research · doi:10.5217/ir.2013.11.1.1 · Cited by 11
Microbiology and Ecology Are Vitally Important to Premedical Curricula
Smith, V. H., Rubinstein, R., Park, S., Kelly, L., & Klepac‐Ceraj, V. (2015) · Evolution Medicine and Public Health · doi:10.1093/emph/eov014 · Cited by 15
Kang, J. R. W., Chung, W., Lim, T.-J., Lim, S., & Nam, Y. (2017) · New Microbes and New Infections · doi:10.1016/j.nmni.2017.05.012 · Cited by 10
“However, recent studies have paid attention to gut microbiota and have suggested that alterations of the intestinal microbiome may contribute to inflammation and the progression of IBD [9,10].”
BackgroundInfluentialTlaskalová-Hogenová, H., Kverka, M., Verdu, E. F., & Wells, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00008-2 · Cited by 10
Ahmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 13
“Direct communication via the vagus nerve, modifications in neurotransmitter metabolism, immunological activation, formation of neuroactive metabolites, and reduction of neurotoxins are some of the hypothesized reasons for the positive effects of FMT (Aroniadis and Brandt 2013).”
Actualité du microbiote intestinal
Bourlioux, P. (2013) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2013.09.001 · Cited by 14
Khajah, M. A. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1347812 · Cited by 11
“difficile infection (CDI) and steroid-resistant acute graft-versus-host disease of the gut [58], and recently in IBD (to be discussed below), this procedure has been performed in non-GIT related diseases, such as obesity, Parkinson’s disease, chronic fatigue syndrome, and autism [59,60].”
MethodWang, H., Liu, S.-P., Ma, T., Yan, W., Zhou, J.-F., Shi, Y., Shen, P., Yang, X., & Wu, S.-N. (2018) · Medicine · doi:10.1097/md.0000000000010675 · Cited by 11
Huang, Y., Pan, P., Echeveste, C. E., Wang, H., Oshima, K., Lin, C., Yearsley, M., Xiao, J., Chen, J., Sun, C., et al. (2020) · Food Frontiers · doi:10.1002/fft2.34 · Cited by 9
“…atherosclerosis, type 2 diabetes, and Parkinson’s disease) (Vaiserman, Koliada, & Marotta, 2017), autism and mood disorders (Mangiola et al., 2016; Li, Han, Dy, & Hagerman, 2017; Choi & Cho, 2016; Yang, Tian, & Yang, 2018), and chronic fatigue syndrome (Xu et al., 2015; Aroniadis & Brandt, 2013).”
BackgroundMicrobiome: The Missing Link in Neuropsychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2017) · EMJ Innovation · doi:10.33590/emjinnov/10313424 · Cited by 10
Mediators of Inflammation and Immune Responses in the Human Gastrointestinal Tract
Arranz, E. M., Peña, A. S., & Bernardo, D. (2013) · Mediators of Inflammation · doi:10.1155/2013/865638 · Cited by 10
“Thus suggesting that intestinal microbiota might be developed as therapeutic agents to increase insulin sensitivity in humans, however, increased knowledge of the intestinal microbiota in health maintenance as well as controlled trials of fecal microbiota transplantation is needed before it can be accepted to be used…”
BackgroundDeepti, I., Chettri, B., Mehra, A., Pinheiro, A. M., & Ravi, R. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_818_2024 · Cited by 9
“It is most commonly used as a treatment for recurrent Clostridioides desdifficile infection (rCDI) 1 .”
Fatima, S. N., Arif, F., Khalid, R., Khan, M., & Naseem, K. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107882 · Cited by 13
Barko, P. C., Nguyen-Edquilang, J., Williams, D. A., & Gal, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294730 · Cited by 10
Gut microbiota and obesity-related gastrointestinal cancer: a focus on epigenetics
Hesson, L. B. (2013) · Translational gastrointestinal cancer · Cited by 11
Kumar, V., Thakur, A. K., Verma, S., Yadav, V., & Chatterjee, S. S. (2015) · TANG [HUMANITAS MEDICINE] · doi:10.5667/tang.2014.0026 · Cited by 10
Chen, H., Tan, P.-S., Li, C., Chen, B., Xu, Y.-Q., He, Y.-Q., & Ke, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/1416236 · Cited by 9
Diao, H., Xiao, Y., Yan, H., Yu, B., He, J., Zheng, P., Yu, J., Mao, X., & Chen, D. (2021) · BioMed Research International · doi:10.1155/2021/9823969 · Cited by 8
Haindl, R., Engel, J., & Kulozik, U. (2021) · Microorganisms · doi:10.3390/microorganisms9051049 · Cited by 10
“The donor must be healthy, must not have taken antibiotics before FMT and must run through extensive screening in advance.”
MethodInfluentialAn Updated Narrative Mini-Review on the Microbiota Changes in Antenatal and Post-Partum Depression
Doroftei, B., Ilie, O., Diaconu, R., Huțanu, D., Stoian, I. L., & Ilea, C. G. (2022) · Diagnostics · doi:10.3390/diagnostics12071576 · Cited by 12
“FMT is usually applied to treat recurrent Clostridium difficile (rCDI) infections, while MTT focuses on metabolic deficiencies [80,81].”
BackgroundNagy, G. G., Várvölgyi, C., & Paragh, G. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29509 · Cited by 8
Trasplante de microbiota fecal: primer caso reportado en Chile y revisión de la literatura
Espinoza, R., Quera, R., Meyer, L., & Rivera, D. (2014) · Revista chilena de infectología · doi:10.4067/s0716-10182014000400016 · Cited by 15
Le transfert de flore digestive : une revue de la littérature
Barbut, F., Collignon, A., Butel, M. J., & Bourlioux, P. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.004 · Cited by 12
ALS Untangled No. 21: Fecal transplants
The ALSUntangled Group (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.814981 · Cited by 7
Gut microbiota and Parkinson’s Disease: a new frontier in understanding neurological health
Kumari, N., Addepalli, V., More, A., Patil, A., & Suryawanshi, M. V. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01726-w · Cited by 9
Boyle, B. L., & Khanna, S. (2024) · Future Microbiology · doi:10.1080/17460913.2024.2364583 · Cited by 9
The Human Gut Microbiome and Its Role in Obesity and the Metabolic Syndrome
Mullin, G. E., & Delzenne, N. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0548-5_7 · Cited by 8
Therapeutic Potential of the Human Gastrointestinal Microbiome
Borody, T. J., Peattie, D. A., & Campbell, J. (2013) · Drug Development Research · doi:10.1002/ddr.21093 · Cited by 8
Huang, Y., Wang, X., Li, X., & Nanhai, P. (2016) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000134 · Cited by 9
Haindl, R., Totzauer, L., & Kulozik, U. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14007 · Cited by 7
“Faecal microbiota transplantation (FMT) has been tested as an alternative treatment method to antibiotics, with recovery rates up to 90% (Gough et al., 2011; Aroniadis and Brandt, 2013).”
MethodMazzawi, T. R. E., Eikrem, Ø., Lied, G. A., & Hausken, T. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/3520686 · Cited by 8
Brave New (Microbial) World: implications for nasal and sinus disorders
Desrosiers, M. Y., & Valera, F. C. P. (2019) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2019.09.001 · Cited by 8
“‘‘Yellow soup’’ made from feces collected from a healthy donor were suggested as treatment of diarrhea as far back as the time of Hippocrates.8 Over the past decade, this has been used clinically for episodes of Clostridium difficile colitis, with often life-saving effects.”
Shor, E. K., Brown, S. P., & Freeman, D. A. (2022) · Journal of Biological Rhythms · doi:10.1177/07487304221092105 · Cited by 7
“FMT is a proven method for transplanting gut bacteria (Borody and Khoruts, 2011; Pamer, 2014) and is increasingly used in health science research (Aroniadis and Brandt, 2013; Smits et al., 2013; Xu et al., 2015).”
Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
Bauer, C. M., Zhang, X., Long, M. D., & Sandler, R. S. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa024 · Cited by 6
Beneficial Microbes: Roles in the Era of Antimicrobial Resistance
Afolayan, A. O., Adetoye, A., & Ayeni, F. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79635 · Cited by 7
Toward Understanding Microbial Ecology to Restore a Degraded Ecosystem
Song, L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20054647 · Cited by 4
“China for treating fo d poisoning or severe diar hea [15].”
BackgroundEffects of early postnatal gastric and colonic microbiota transplantation on piglet gut health
Larsen, C., Offersen, S. M., Brunse, A., Pirolo, M., Kar, S. K., Guadabassi, L., & Thymann, T. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00954-w · Cited by 6
“Previously, FMT has been used to re-establish a normal gut microbiome in humans to cure Clostridioides difficile infections [13, 14].”
MethodThe Pulmonary Microbiome, Mechanical Ventilation, and Trauma
Smith, A. D., Zhang, Y., & Shewale, S. (2012) · Biological Systems Open Access · doi:10.4172/2329-6577.1000116 · Cited by 5
“Interestingly, new treatments for the latter by fecal transplantation have shown dramatic effects [57,58].”
BackgroundRole of probiotics and nutrition in the management of chronic inflammatory bowel disease in children
Quah, S. H. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013069 · Cited by 7
Gastroenteritis aguda y Haemophilus parainfluenzae: una asociación previsible pero no reportada
Olivart, M., Galera, E., & Falguera, M. (2016) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2015.10.010 · Cited by 5
da Luz, M. R. M. P., & Waizbort, R. (2020) · História Ciências Saúde-Manguinhos · doi:10.1590/s0104-59702020000400009 · Cited by 7
Fecal Microbiota Transplantation
Borody, T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00018-0 · Cited by 7
Nagy, G., Várvölgyi, C., Balogh, Z., Orosi, P., & Paragh, G. (2012) · Orvosi Hetilap · doi:10.1556/oh.2013.29514 · Cited by 6
Microbiota-Gut-Brain-Axis and Autism Spectrum DisordersPreprint
Srikantha, P., & Mohajeri, M. H. (2018) · Preprints.org · doi:10.20944/preprints201811.0171.v1 · Cited by 4
“The donated stool sample is normally used freshly within eight hours, or within eight weeks when directly frozen after the passage [124].”
BackgroundZhou, H. W., Yu, B., Sun, J., Chen, H., Liu, Z., Ge, L., & Chen, D. (2023) · Animal Biotechnology · doi:10.1080/10495398.2023.2248200 · Cited by 6
Introductory Chapter: Inflammatory Bowel Disease
Mahdi, B. M. (2018) · InTech eBooks · doi:10.5772/intechopen.73512 · Cited by 4
Acute gastroenteritis and Haemophilus parainfluenzae: An unreported but predictable association
Olivart, M., Galera, E., & Falguera, M. (2017) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2015.10.004 · Cited by 4
Tiburcio, Á. Z. (2019) · Gastroenterology Medicine & Research · doi:10.31031/gmr.2019.03.000551 · Cited by 4
Ko, Y., Kim, S., Pan, C., & Park, K. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3100893 · Cited by 4
“Dysbiosis in a microbial community has been known to be associated with several chronic diseases such as cancer [5], [6], constipation [7], diabetes [8], multiple sclerosis [9], autoimmune disease, obesity [8], metabolic syndrome, autism [10], and behavioral disorder [11].”
BackgroundThe Importance of Fecal Transplantation in Personalized Medicine
Coşkunpınar, E. M., İSLAMZADE, F., YILMAZ, E. P., Örs, C. H., Hüseyin, A. D. A. K., YEŞILTEPE, A., TÜRKSOYLU, S., & Dural, A. C. (2017) · Bezmialem Science · doi:10.14235/bs.2018.1997 · Cited by 4
A Vision for Investigating the Microbiology of Health and Disease
Lipkin, W. I. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu649 · Cited by 4
“spired fecal transplant interventions in a wide range of disorders, from autism to cancer [18].”
BackgroundLuczynski, P., Neufeld, K. M., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00007-4 · Cited by 3
LIAO, Y., Li, X., Li, Q., Wang, Y., TAN, X., & GONG, T. (2024) · Biocell · doi:10.32604/biocell.2024.050324 · Cited by 3
Clostridium difficile Infection Is on the Rise
Kenneley, I. L. (2014) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000444501.54723.5b · Cited by 3
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
Moon, C. M., & Hong, S. N. (2021) · Clinical Endoscopy · doi:10.5946/ce.2021.068 · Cited by 4
“When FMT was performed on 18 patients with metabolic syndrome using their own or the underweighted person’s stool, nine patients who received stool from people with underweight body mass index (BMI) had noticeably reduced triglyceride levels and increased insulin sensitivity compared to the control group.(29) In anoth…”
BackgroundFMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Fecal Microbiota Transplantation in the Treatment-Resistant Psychiatric Disorders
Evrensel, A., & Ceylan, M. E. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_24 · Cited by 5
Al-Sahlanee, B. J. A., Senyuk, I. V., Lenchyk, L. V., & Upyr, T. V. (2019) · Farmatsevtychnyi zhurnal · doi:10.32352/10.32352/0367-3057.6.19.10 · Cited by 3
Savigamin, C., Mahakit, N., Stithit, S., & Samuthpongtorn, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.746230 · Cited by 3
The Human Microbiome, Conventional Medicine, and Homeopathy
Whitmont, R. D. (2020) · Homeopathy · doi:10.1055/s-0040-1709665 · Cited by 7
ROSENBERG, E. B. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-65317-0_1 · Cited by 4
Nieuwdorp, M., Vrieze, A., & de Vos, W. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.036 · Cited by 3
FMT Regulatory Challenges and the Lived Experiences of People With IBD
Haw, J., Chuong, K. H., & O’Doherty, K. C. (2017) · The American Journal of Bioethics · doi:10.1080/15265161.2017.1299253 · Cited by 3
“…in a number of health conditions, most notably Clostridium difficile infections (CDI) and potentially other gastrointestinal disorders (Allen-Vercoe et al. 2012; Aroniadis and Brandt 2013), there is increasing need to address regulatory challenges and their associated ethical and social issues.”
BackgroundBornbusch, S. L., Harris, R. L., Grebe, N. M., Roche, K. E., Dimac-Stohl, K. A., & Drea, C. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.11.378349 · Cited by 3
Immunomodulatory Effects of Microbiome-Derived Therapies
Ghosh, K., & Sands, D. I. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_4 · Cited by 4
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
Modulation of the Gut Ecosystem in Irritable Bowel Syndrome
König, J., & Brummer, R. J. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-06151-1_4 · Cited by 2
Importance of gut microbiota in health and diseases of new born infants
Gao, J., WU, H., & Liu, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3253 · Cited by 3
“Furthermore, a recent study showed the existence of a correlation among insulin resistance and intestinal microflora during a metabolic syndrome (42).”
BackgroundUnderstanding of Gut Microbial Ecology for New Therapeutics
Joishy, T. K., Das, S., & Khan, M. R. (2021) · Springer eBooks · doi:10.1007/978-981-16-5617-0_13 · Cited by 2
Chen, Y., Lv, T., Dong, Y., Zheng, L., Zheng, B., Wang, J., Gu, S., & Li, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.825189 · Cited by 2
DISBIOSIS CORRECTION - THE BASIS OF REGENERATIVE MEDICINE
Mikhailova, N. A., Voevodin, D. A., & Поддубиков, А. В. (2018) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2018-5-107-113 · Cited by 2
Towards treatments targeting the gut to improve behavioural outcomes in autism spectrum disorder
Munira, M. S., Stevens, J. E., Shahin, W., Wang, K., Franks, A. E., Perez, A. R. J., Scott, J. W., & Hill‐Yardin, E. L. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-025-03061-4 · Cited by 1
Recent advances and clinical relevance of microbiome dynamics in health and disease
Gavanji, S., Suhail, M., Bencúrová, E., Dandekar, T., & Othman, E. M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2679197 · Cited by 4
“87,91 The adherent-invasive E. coli (AIEC) strain has been shown to adhere to and invade intestinal epithelial cells, stimulate tumor necrosis factor-alpha (TNF-α) production, and activate NF-κB signaling pathways, thereby promoting chronic mucosal inflammation.”
Fecal Microbiota Transplantation: An Interest in IBD?
Kahn, S. A., Goeppinger, S. R., & Rubin, D. T. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360715 · Cited by 1
Normal Mikrobiyal Floranın İnsan Sağlığı Üzerine Etkisi ve İnsan Mikrobiyom Projesi
Bozok, T., Şimşek, T., Kömür, S., & Ulu, A. (2014) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.38003 · Cited by 4
Recent Update in Fecal Microbiota Transplantation
Kim, H., Kang, K., Kim, S.-J., & Im, E. (2014) · The Korean Journal of Microbiology · doi:10.7845/kjm.2014.4072 · Cited by 2
“또한 18명의 대사증후군환자에게 자신 또는 저체중인 사람의 변을 이용하여 FMT를 실시하였을 때 저체중인 사람의 변을 이식받은 9명은 트리글리세리드의 수치가 눈에 띄게 감소 하였고 인슐린 민감도가 자신의 변을 이용하여 FMT를 실시한 대조군 보다 증가하였다(Aroniadis and Brandt, 2013).”
Fecal microbiota transplantation: why, who, how?
Yalçın, S. S., & Kanatlı, M. Ç. (2015) · Pamukkale Medical Journal · doi:10.5505/ptd.2015.22448 · Cited by 2
“Kronik yorgunluk sendromu ve gastrointestinal şikayetleri olan 60 vakada yapılan kontrolsüz çalışmada vakaların %50’sinin IMT sonrası uyku bozuklukları ve yorgunluk yakınmalarında düzelme saptanmıştır [27,28].”
ADVANCES IN TRANSLATIONAL SCIENCE
Sellin, J. H., Murthy, S. K., Goetz, M., Hoffman, A. W., & Kießlich, R. (2012) · Cited by 1
Epigenetic Effects of Gut Microbiota on Obesity and Gastrointestinal Cancers
Kuroiwa‐Trzmielina, J., & Hesson, L. B. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41610-6_7 · Cited by 1
Fecal Microbiota Transplantation: A Novel Way to Treat Gastrointestinal Disorders
Horowitz, S. (2013) · Alternative and Complementary Therapies · doi:10.1089/act.2013.19202 · Cited by 1
Probiotics and Prebiotics on Intestinal Flora and Gut Health
Peng, M., Kennedy, N.-F., Truong, A., Arriola, B., & Akmel, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-47384-6_4 · Cited by 3
Irritable Bowel Syndrome (IBS): A Review
Hamarashid, B. R., Dalkılıç, S., Dalkılıç, S., Saleh, K., & Kırbağ, S. (2020) · Advances in BioScience (Not affiliated with any institute repository.) · Cited by 4
Shah, F., & Dwivedi, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_4 · Cited by 2
The Microbiota and Its Modulation in Immune-Mediated Disorders
Pevsner‐Fischer, M., Rot, C., Tuganbaev, T., & Elinav, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803302-9.00010-5 · Cited by 2
Ovallath, S., & Sulthana, B. (2018) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_4_18 · Cited by 1
“Several case reports of patients with PD and other neurodegenerative diseases have shown improvement in gastrointestinal tract (GIT) and non-GIT symptoms with fecal microbial transplantation and/or antibiotic regimen, again emphasizing on the importance of the gut microbiota in PD.[15,105,106]”
BackgroundMining Human Microbiome for Therapeutics
Ghattargi, V. C., Sape, K., Kumbhare, S. V., & Shouche, Y. S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8315-1_18 · Cited by 2
The Human Intestinal Microbiota and Microbiome
Koren, O., & Ley, R. E. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch32 · Cited by 2
Biofilm Control Strategies in Dental Health
Frias‐Lopez, J. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_14 · Cited by 2
Trice, T. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/7777329
Microbiote et syndrome de l’intestin irritable (SII) : où en sommes-nous, où allons-nous ?
Duboc, H. (2013) · Côlon & Rectum · doi:10.1007/s11725-013-0459-5
Editorial Mediators of Inflammation and Immune Responses in the Human Gastrointestinal Tract
Arranz, E. M., Peña, A. S., & Bernardo, D. (2013)
Davey, K. J. (2013) · Cork Open Research Archive (University College Cork, Ireland)
Smith, A. D. (2015) · Digital Commons @ UNT Health Science Center · Cited by 2
Chan, C. (2016) · Scholarship - Claremont (Claremont Colleges)
Gut Microbiota in Human Health and Diseases
Rauch, M., & Lynch, S. V. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00131-8
The development of a microbiome reference that spans thousands of individuals
McDonald, D. T. (2015) · CU Scholar (University of Colorado Boulder)
Transplantatie van fecale microbiota : oude wijn in nieuwe zakken?
Holvoet, T., de Wiele, T. V., Boelens, J., Raes, J., Hindryckx, P., Vos, M. D., & Looze, D. A. D. (2014) · Ghent University Academic Bibliography (Ghent University)
Koleilat, A. (2017) · Gastroenterology & Hepatology International Journal · doi:10.23880/ghij-16000131
Savelkoul, E. H. J., Pathmakanthan, S., Hawkey, P. M., & Iqbal, T. H. (2018) · Gastrointestinal Nursing · doi:10.12968/gasn.2018.16.9.43 · Cited by 1
Küçük, M. P., & Ülger, F. (2019) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybd.galenos.2019.70883 · Cited by 4
Metadata
- Authors
- Aroniadis, O. C., & Brandt, L. J.
- Affiliations
- Montefiore Medical Center (US)
- Corresponding author
- Aroniadis, Olga C.
- Venue
- Current Opinion in Gastroenterology
- Published
- 2013-01
- Volume
- 29
- Issue
- 1
- Pages
- 79-84
- ISSN
- 0267-1379 (ISSN-L)
- OpenAlex
- W2025589766
- Cited by
- 336
- References
- 51
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 9 · 2022: 33 · 2021: 25 · 2020: 36 · 2019: 27 · 2018: 27 · 2017: 22 · 2016: 29 · 2015: 27 · 2014: 38 · 2013: 29
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, gut microbiota, Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, chronic constipation, autoimmune disease, obesity, chronic fatigue syndrome, neuropsychiatric disorders, energy metabolism, cell-mediated immunity
- MeSH terms
- Autistic Disorder, Autoimmune Diseases, Constipation, Enterocolitis, Pseudomembranous, Feces, Humans, Nervous System Diseases, Obesity, Recurrence, Inflammatory Bowel Diseases, Fatigue Syndrome, Chronic, Clostridioides difficile, Irritable Bowel Syndrome, Donor Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.